| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
AFP
|
alpha-fetoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AK1
|
adenylate kinase 1
|
|
AK7
|
adenylate kinase 7
|
|
AK8
|
adenylate kinase 8
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AP4M1
|
adaptor-related protein complex 4, mu 1 subunit
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOL1
|
apolipoprotein L, 1
|
|
ASF1A
|
anti-silencing function 1A histone chaperone
|
|
ASF1B
|
anti-silencing function 1B histone chaperone
|
|
ATF4
|
activating transcription factor 4
|
|
ATF6
|
activating transcription factor 6
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
B3GAT2
|
beta-1,3-glucuronyltransferase 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BBS1
|
Bardet-Biedl syndrome 1
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C19ORF48
|
chromosome 19 open reading frame 48
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD160
|
CD160 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD52
|
CD52 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD8A
|
CD8a molecule
|
|
CDC34
|
cell division cycle 34
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYGB
|
cytoglobin
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DCK
|
deoxycytidine kinase
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DGUOK
|
deoxyguanosine kinase
|
|
DMD
|
dystrophin
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DSPP
|
dentin sialophosphoprotein
|
|
EDAR
|
ectodysplasin A receptor
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EP300
|
E1A binding protein p300
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
EXTL2
|
exostosin-like glycosyltransferase 2
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF23
|
fibroblast growth factor 23
|
|
FOXP3
|
forkhead box P3
|
|
FXN
|
frataxin
|
|
GAN
|
gigaxonin
|
|
GHR
|
growth hormone receptor
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HGD
|
homogentisate 1,2-dioxygenase
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HP
|
haptoglobin
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
KDM5D
|
lysine (K)-specific demethylase 5D
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KITLG
|
KIT ligand
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LMNA
|
lamin A/C
|
|
MAN1B1
|
mannosidase, alpha, class 1B, member 1
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCOLN1
|
mucolipin 1
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOCS3
|
molybdenum cofactor synthesis 3
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYO7A
|
myosin VIIA
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NFS1
|
NFS1 cysteine desulfurase
|
|
NGB
|
neuroglobin
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OXCT1
|
3-oxoacid CoA transferase 1
|
|
PARK7
|
parkinson protein 7
|
|
PAX6
|
paired box 6
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKP1
|
plakophilin 1
|
|
PLP1
|
proteolipid protein 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RHD
|
Rh blood group, D antigen
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RS1
|
retinoschisin 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SELL
|
selectin L
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SFTPD
|
surfactant protein D
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC35D2
|
solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TERT
|
telomerase reverse transcriptase
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THPO
|
thrombopoietin
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMC1
|
transmembrane channel-like 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TRAPPC2
|
trafficking protein particle complex 2
|
|
TTN
|
titin
|
|
UBC
|
ubiquitin C
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT3A1
|
UDP glycosyltransferase 3 family, polypeptide A1
|
|
URM1
|
ubiquitin related modifier 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
